Assyro AI

Orange Book product · Generic (ANDA)

IBUPROFEN

IBUPROFEN

Generic (ANDA)ANDA 202312OTC GRANULES

At a glance

Oct 07, 2016

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 07, 2016

    9 yr 10 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

IBUPROFEN

Strength

200MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

ANDA 202312

Product number

001

Marketing status

OTC

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of IBUPROFEN

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.